Cargando…
Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of Multiple Sclerosis
Autores principales: | Wang, Xiaofang, Kimbrel, Erin A., Ijichi, Kumiko, Paul, Debayon, Lazorchak, Adam S., Chu, Jianlin, Kouris, Nicholas A., Yavanian, Gregory J., Lu, Shi-Jiang, Pachter, Joel S., Crocker, Stephen J., Lanza, Robert, Xu, Ren-He |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878825/ https://www.ncbi.nlm.nih.gov/pubmed/33567293 http://dx.doi.org/10.1016/j.stemcr.2021.01.004 |
Ejemplares similares
-
Human ESC-Derived MSCs Outperform Bone Marrow MSCs in the Treatment of an EAE Model of Multiple Sclerosis
por: Wang, Xiaofang, et al.
Publicado: (2014) -
Human ES-derived MSCs correct TNF-α-mediated alterations in a blood–brain barrier model
por: Ge, Shujun, et al.
Publicado: (2019) -
The role of MSCs and CAR-MSCs in cellular immunotherapy
por: Yan, Lun, et al.
Publicado: (2023) -
The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS)
por: Al Jumah, Mohammed A., et al.
Publicado: (2012) -
Appearance of claudin-5(+) leukocyte subtypes in the blood and CNS during progression of EAE
por: Krajewski, Dylan, et al.
Publicado: (2021)